National Academies Press: OpenBook
« Previous: 4 Reflections and Looking Forward
Suggested Citation:"References." Institute of Medicine and National Academy of Engineering. 2015. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework. Washington, DC: The National Academies Press. doi: 10.17226/18763.
×

References

Arrow, K. 1950. A difficulty in the concept of social welfare. Journal of Political Economy 58:328–346.

Bloom, D. E., D. Canning, and M. Weston. 2005. The value of vaccination. World Economics 6(3):15–39.

De Gregorio, E., and R. Rappuoli. 2014. From empiricism to rational design: A personal perspective of the evolution of vaccine development. Nature Reviews Immunology 14(7):505–514.

Dye, C. 2014. After 2015: Infectious diseases in a new era of health and development. Philosophical Transactions of the Royal Society of London B: Biological Sciences 369(1645):20130426.

Edwards, W., and F. H. Barron. 1994. SMARTS and SMARTER: Improved simple methods for multiattribute utility measurement. Organizational Behavior and Human Decision Processes 60(3):306–325.

Emerson, R. W. 1892. The Conduct of Life: New and Revised Edition. Cambridge, MA: The Riverside Press/Houghton, Mifflin and Company.

Gibbard, A. 1973. Manipulation of voting schemes: A general result. Econometrica 41(4):587–601.

Greenwood, B. 2014. The contribution of vaccination to global health: Past, present and future. Philosophical Transactions of the Royal Society of London B: Biological Sciences 369(1645):20130433.

HHS (U.S. Department of Health and Human Services). 2011. 2010 National Vaccine Plan: Protecting the Nation’s Health Through Immunization. Washington, DC: U.S. Department of Health and Human Services.

Hinman, A. R., W. A. Orenstein, and A. Schuchat. 2011. Vaccine-preventable diseases, immunizations, and MMWR: 1961–2011. Morbidity and Mortality Weekly Report 60(4):49–57.

IOM (Institute of Medicine). 1985. New Vaccine Development: Establishing Priorities (Volume 1: Diseases of Importance in the United States). Washington, DC: National Academy Press.

Suggested Citation:"References." Institute of Medicine and National Academy of Engineering. 2015. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework. Washington, DC: The National Academies Press. doi: 10.17226/18763.
×

IOM. 1986. New Vaccine Development: Establishing Priorities (Volume 2: Diseases of Importance in Developing Countries). Washington, DC: National Academy Press.

IOM. 2000. Vaccines for the 21st Century: A Tool for Decision Making. Washington, DC: National Academy Press.

IOM. 2012. Ranking Vaccines: A Prioritization Framework: Phase I: Demonstration of Concept and a Software Blueprint. Washington, DC: The National Academies Press.

IOM. 2013. Ranking Vaccines: A Prioritization Software Tool: Phase II: Prototype of a Decision-Support System. Washington, DC: The National Academies Press.

Jamison, D. T., L. H. Summers, G. Alleyne, K. J. Arrow, S. Berkley, et al. 2013. Global health 2035: A world converging within a generation. Lancet 382(9908):1898–1955.

Kotter, J. P. 1995. Leading change: Why transformation efforts fail. Harvard Business Review March–April: 59–67.

Lozano, R., M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, J. Abraham, T. Adair, R. Aggarwal, S. Y. Ahn, et al. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2095–2128.

Murray, C. J., M. Ezzati, A. D. Flaxman, S. Lim, R. Lozano, C. Michaud, M. Naghavi, J. A. Salomon, K. Shibuya, T. Vos, D. Wikler, and A. D. Lopez. 2012. GBD 2010: Design, definitions, and metrics. Lancet 380(9859):2063–2066.

Nabel, G. J. 2013. Designing tomorrow’s vaccines. New England Journal of Medicine 368(6):551–560.

NRC (National Research Council). 1998. From Death to Birth: Mortality Decline and Reproductive Change. Washington, DC: National Academy Press.

Phelps, C., G. Madhavan, K. Sangha, R. Rappuoli, R. Colwell, R. Martinez, P. Kelley, and L. King. 2014. SMART Vaccines: A priority setting aid for new vaccine candidates. Proceedings of the National Academy of Sciences of the United States of America 111(9):3199–3200.

Rappuoli, R., M. Pizza, G. del Giudice, and E. De Gregorio. 2014. Vaccines: New opportunities for a new society. Proceedings of the National Academy of Sciences of the United States of America 111(34):12288–12293.

Reny, P. J. 2001. Arrow’s theorem and the Gibbard-Satterthwaite theorem: A unified approach. Economics Letters 70:99–105.

Suggested Citation:"References." Institute of Medicine and National Academy of Engineering. 2015. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework. Washington, DC: The National Academies Press. doi: 10.17226/18763.
×

Roush, S. W., T. V. Murphy, and the Vaccine-Preventable Disease Table Working Group. 2007. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 298(18):2155–2163.

Satterthwaite, M. A. 1975. Strategy-proofness and Arrow’s conditions: Existence and correspondence theorems for voting procedures and social welfare functions. Journal of Economic Theory 10:187–217.

van Panhuis, W. G., W, J. Grefenstette, S. Y. Jung, et al. 2013. Contagious diseases in the United States from 1888 to the present. New England Journal of Medicine 369(22):2152–2158.

Whitney, C. G., F. Zhou, J. Singleton, and A. Schuchat. 2014. Benefits from immunization during the vaccines for children program era—United States, 1994–2013. Morbidity and Mortality Weekly Report 63(16):352–355.

Suggested Citation:"References." Institute of Medicine and National Academy of Engineering. 2015. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework. Washington, DC: The National Academies Press. doi: 10.17226/18763.
×

This page intentionally left blank.

Suggested Citation:"References." Institute of Medicine and National Academy of Engineering. 2015. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework. Washington, DC: The National Academies Press. doi: 10.17226/18763.
×
Page 81
Suggested Citation:"References." Institute of Medicine and National Academy of Engineering. 2015. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework. Washington, DC: The National Academies Press. doi: 10.17226/18763.
×
Page 82
Suggested Citation:"References." Institute of Medicine and National Academy of Engineering. 2015. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework. Washington, DC: The National Academies Press. doi: 10.17226/18763.
×
Page 83
Suggested Citation:"References." Institute of Medicine and National Academy of Engineering. 2015. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework. Washington, DC: The National Academies Press. doi: 10.17226/18763.
×
Page 84
Next: Appendix A: Use Case Scenarios Report for SMART Vaccines »
Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework Get This Book
×
Buy Paperback | $75.00 Buy Ebook | $59.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

SMART Vaccines - Strategic Multi-Attribute Ranking Tool for Vaccines - is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine development. A blueprint for this computer-based guide was presented in the 2012 report Ranking Vaccines: A Prioritization Framework: Phase I. The 2013 Phase II report refined a beta version of the model developed in the Phase I report.

Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework extends this project by demonstrating the practical applications of SMART Vaccines through use case scenarios in partnership with the Public Health Agency of Canada, New York State Department of Health, and the Serum Institute of India. This report also explores a novel application of SMART Vaccines in determining new vaccine product profiles, and offers practical strategies for data synthesis and estimation to encourage the broader use of the software.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!